Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Chronotype Alignment and Time Perception

29. Juni 2026 aktualisiert von: Dr YU Cehao, The Hong Kong Polytechnic University

Circadian Match and Mismatch Effects on Temporal Cognition in Morning- and Evening-Type Adults

People differ in chronotype - whether they function best in the morning ("larks") or the evening ("owls"). This study asks whether the match or mismatch between a person's chronotype and the time of day at which they are tested changes how they perceive time.

Healthy morning-type and evening-type adults at three sites (Aarhus, Denmark; Changzhou, China; and Hong Kong) complete the same battery of perception and cognition tasks twice - once in the early morning (about 08:00) and once late in the evening (about 22:00), in counterbalanced order. The primary outcome is the accuracy (signed bias) of time-perception judgements; the key comparison is the interaction between chronotype and time of day (the "synchrony effect").

Secondary measures include timing precision, the subjective passage of time, sleepiness, mood, colour perception (with and without blue-blocking glasses) and perceptual decision-making. By testing the same protocol across three cultures and latitudes, the study examines whether circadian match/mismatch effects on temporal cognition generalise across populations.

Studienübersicht

Detaillierte Beschreibung

Background and rationale: Time perception is shaped by attention and physiological arousal, both of which follow a circadian rhythm that differs systematically between morning-type and evening-type individuals. The "synchrony effect" holds that performance is optimal when testing occurs at a person's circadian-preferred time. Whether this match/mismatch alters the perceived speed and precision of an internal clock, and whether any such effect generalises across cultures and latitudes, is not well established.

Design: a 2 (chronotype: morning-type vs evening-type; between-subjects) x 2 (session time: morning about 08:00 vs evening about 22:00; within-subjects, counterbalanced) mixed design, replicated at three sites. "Match" = tested at the circadian-preferred time; "mismatch" = tested at the non-preferred time. Site is included as an additional factor for generalisability.

Procedure: volunteers are screened online (Morningness-Eveningness Questionnaire to classify chronotype, with intermediate types excluded; Munich ChronoType Questionnaire; Pittsburgh Sleep Quality Index; demographics; colour-vision and health checks) and keep a 7-day sleep diary. Eligible participants attend two laboratory sessions and complete an identical battery each time: time-perception tasks (interval production/estimation, duration discrimination, passage-of-time judgement), state measures (sleepiness, mood, arousal), colour tasks (unique-hue settings with and without blue-blocking glasses; an ambiguous-colour image), a perceptual conformity task, and a vigilance task.

Primary hypothesis: a chronotype-by-time-of-day interaction on time-perception bias. Analysis uses linear mixed-effects models (participant as a random effect; chronotype, session time, their interaction, and site as fixed effects), with false-discovery-rate correction across secondary outcomes. Session order is counterbalanced to separate time-of-day from practice and order effects.

Studientyp

Interventionell

Einschreibung (Geschätzt)

240

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Healthy adult, 18-40 years
  • Clear morning-type or evening-type on the Morningness-Eveningness Questionnaire (MEQ-SA); intermediate types excluded (state exact cut-offs, e.g. evening-type 41 or below, morning-type 59 or above)
  • Normal or corrected-to-normal visual acuity
  • Normal colour vision (e.g. Ishihara screening)
  • Fluent in the testing-site language (Danish, Chinese, or English)
  • Able to attend both an early-morning (about 08:00) and a late-evening (about 22:00) session

Exclusion Criteria:

  • Intermediate chronotype (MEQ in the middle band)
  • Night or rotating shift work in the past 3 months, or recent trans-meridian travel (more than 2 time zones in the past 4 weeks)
  • Diagnosed sleep disorder (e.g. insomnia, sleep apnoea)
  • Current psychiatric or neurological disorder
  • Use of sleep medication or psychoactive or CNS-active drugs
  • Colour-vision deficiency
  • Substance-use disorder

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Morning-first sequence
Participants complete the Morning test session (about 08:00) first, then the Evening test session (about 22:00). Both sessions use the identical perception and cognition battery; session order is counterbalanced across participants.
Full perception and cognition battery administered shortly after habitual wake (about 08:00): time-perception tasks (interval production/estimation, duration discrimination, passage-of-time judgement), state measures (sleepiness, mood, arousal), colour tasks, a perceptual conformity task, and a vigilance task.
The identical battery administered late in the evening (about 22:00), enabling within-participant comparison of the same measures at the two times of day.
Experimental: Evening-first sequence
Participants complete the Evening test session (about 22:00) first, then the Morning test session (about 08:00). Both sessions use the identical perception and cognition battery; session order is counterbalanced across participants.
Full perception and cognition battery administered shortly after habitual wake (about 08:00): time-perception tasks (interval production/estimation, duration discrimination, passage-of-time judgement), state measures (sleepiness, mood, arousal), colour tasks, a perceptual conformity task, and a vigilance task.
The identical battery administered late in the evening (about 22:00), enabling within-participant comparison of the same measures at the two times of day.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Time-perception bias measured by the two-alternative forced-choice duration-comparison point of subjective equality
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants complete a two-alternative forced-choice duration-comparison task. On each trial, they judge whether a comparison interval is shorter or longer than a standard interval. A psychometric function is fitted to each participant's responses to estimate the point of subjective equality, defined as the comparison duration judged longer than the standard on 50% of trials. Time-perception bias is calculated as signed percentage error: ((point of subjective equality - standard duration) / standard duration) × 100. Positive values indicate a point of subjective equality above the standard duration; negative values indicate a point of subjective equality below the standard duration. The primary comparison is the chronotype-by-session-time interaction, testing whether time-perception bias differs between circadian match and mismatch sessions.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Temporal precision measured by the two-alternative forced-choice duration-discrimination Weber fraction
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants complete a two-alternative forced-choice duration-discrimination task using an adaptive staircase procedure. On each trial, they judge whether a comparison interval is shorter or longer than a standard interval. A psychometric function is fitted to estimate the just-noticeable difference, defined as the smallest duration difference required for reliable discrimination. Temporal precision is calculated as the Weber fraction: just-noticeable difference divided by the standard duration. Lower Weber-fraction values indicate better temporal precision, whereas higher values indicate poorer temporal precision.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Subjective passage of time measured by a passage-of-time rating scale
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants rate their subjective passage of time during the laboratory session using a passage-of-time rating scale. The scale ranges from 1 to 7, where 1 indicates that time passed very slowly and 7 indicates that time passed very quickly. Higher scores indicate a faster subjective passage of time, whereas lower scores indicate a slower subjective passage of time.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Subjective sleepiness measured by the Karolinska Sleepiness Scale
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Subjective sleepiness is assessed using the Karolinska Sleepiness Scale, a 9-point self-report scale ranging from 1 to 9. A score of 1 indicates very alert, and a score of 9 indicates very sleepy or fighting sleep. Higher scores indicate greater subjective sleepiness. The scale is administered before and after the laboratory task battery in each session; the outcome will be analysed as session-level subjective sleepiness, with pre- and post-battery ratings used to characterise changes across the session.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Mood measured by the Multidimensional Mood Questionnaire
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Mood is assessed using the Multidimensional Mood Questionnaire. The questionnaire provides three bipolar mood dimensions: good-bad mood, awake-tired mood, and calm-nervous mood. Each dimension is scored from 4 to 20. Higher scores indicate a more positive mood state: better mood on the good-bad dimension, greater wakefulness on the awake-tired dimension, and greater calmness on the calm-nervous dimension.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Unique-hue settings measured as hue angle in the Commission Internationale de l'Éclairage Colour Appearance Model 2016 (CIECAM16)
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants complete a unique-hue adjustment task for unique yellow, blue, green, and red. For each unique hue, the selected colour is converted to a hue angle in the Commission Internationale de l'Éclairage Colour Appearance Model 2016 (CIECAM16). Hue angle is measured in degrees (0°-360°), representing the location of the selected colour around the hue circle. The task is completed both with and without blue-blocking glasses. Hue angle is an angular colour-coordinate measure; higher or lower values do not indicate a better or worse outcome but indicate a shift in the perceived unique-hue setting.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Ambiguous-colour image perception measured by forced-choice categorisation of the dress image
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants view the ambiguous dress image and complete a forced-choice categorisation task. They indicate whether they perceive the image as white/gold or blue/black. The outcome is the categorical response to the image, recorded separately with and without blue-blocking glasses. This measure indexes individual differences in colour-perception interpretation and illuminant assumptions, and whether the perceived category shifts with reduced short-wavelength input or time of day. This is a categorical perceptual outcome; higher or lower values do not indicate a better or worse outcome.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Perceptual conformity measured by change in perceptual judgement after social-response exposure
Zeitfenster: Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.
Participants complete a perceptual judgement task before and after exposure to others' responses. Perceptual conformity is measured as the change in the participant's judgement from the initial response to the post-exposure response. Larger absolute change scores indicate greater susceptibility to social influence on perception. Positive or negative scores indicate the direction of change relative to the participant's initial judgement or relative to the displayed social response, depending on the specific perceptual judgement scale used.
Each of two laboratory sessions, morning about 08:00 and evening about 22:00, completed within about 2 weeks.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. September 2025

Primärer Abschluss (Geschätzt)

30. Juni 2028

Studienabschluss (Geschätzt)

30. Juni 2028

Studienanmeldedaten

Zuerst eingereicht

22. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

29. Juni 2026

Zuerst gepostet (Tatsächlich)

30. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

30. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

29. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified individual participant data underlying the published results, together with the study protocol, statistical analysis plan, and analysis code, will be made openly available via the Open Science Framework (OSF).

IPD-Sharing-Zeitrahmen

Beginning after publication of the primary results, with no planned end date.

IPD-Sharing-Zugriffskriterien

Open access via the Open Science Framework; no application required.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT
  • ANALYTIC_CODE

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Schlafen

Abonnieren